Evaluation of Accuvein in Cirrhotics Patients

NCT ID: NCT03996135

Last Updated: 2022-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

280 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-15

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the effectiveness of AccuVein AV400 to facilitate placement of peripheral intravenous catheters in cirrhotic adults by comparing the success rate of the first attempt to install a peripheral venous catheter with or without AccuVein AV400®.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Cirrhosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental : Cannulation with AccuVein AV400

Cirrhotic patients benefit from the support of a venous illumination device for each peripheral venous cannulation

Group Type EXPERIMENTAL

Cannulation with AccuVein AV400

Intervention Type DEVICE

Cannulation using AccuVein AV400 device

Control

Cirrhotic patients benefit from the standard technique of peripheral veinous catheter placement.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cannulation with AccuVein AV400

Cannulation using AccuVein AV400 device

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AccuVein AV400

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient older than 18 years old
* Patient presenting a liver cirrhosis
* Patient requiring the placement of a venous peripheral catheter
* Patient informed and giving free and informed consent
* Patient affiliated to a French social security scheme

Exclusion Criteria

* Patient under 18 years old
* Patient unable to give consent
* Patient under guardianship or curatorship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Caen University Hospital

Caen, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philippe Moiteaux

Role: CONTACT

0231064542

Nelly Orliac

Role: CONTACT

0231063082

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Philippe Moiteaux

Role: primary

+33231063106

Clémence Tomadesso

Role: backup

+33231065386

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-043

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.